Future studies on both expression and signaling of SMAD3 in brain and peripheral human samples, as well as in experimental models are required to further investigate functional consequences of this molecule for AD and its vascular, Aβ and neurodegeneration-related outcomes. This evidence concerns the gene SMAD3 and Alzheimer disease.